These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 8095897

  • 1. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
    Marin C, Chase TN.
    Eur J Pharmacol; 1993 Feb 09; 231(2):191-6. PubMed ID: 8095897
    [Abstract] [Full Text] [Related]

  • 2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 09; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 3. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep 09; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 4. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 09; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM, Marin C, Susel Z, Chase TN.
    Eur J Pharmacol; 1993 Jun 04; 236(3):385-93. PubMed ID: 8102970
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY, Zhou LW, Friedman E, Weiss B.
    Neuropharmacology; 1993 Jan 04; 32(1):85-91. PubMed ID: 8094235
    [Abstract] [Full Text] [Related]

  • 7. The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.
    Mittleman G, LeDuc PA, Whishaw IQ.
    Behav Brain Res; 1993 Jun 30; 55(2):253-67. PubMed ID: 8102851
    [Abstract] [Full Text] [Related]

  • 8. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun 30; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 9. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ, Yu J, Marshall JF.
    Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797
    [Abstract] [Full Text] [Related]

  • 10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 15; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 11. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF, Aloyo VJ, Weiss B.
    Neuroscience; 1993 Jun 15; 54(3):669-80. PubMed ID: 8101360
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.
    Eilam D, Talangbayan H, Canaran G, Szechtman H.
    Psychopharmacology (Berl); 1992 Jun 15; 106(4):447-54. PubMed ID: 1533720
    [Abstract] [Full Text] [Related]

  • 13. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM, Mohell N, Bengtsson A, Malmberg A.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):137-44. PubMed ID: 7498268
    [Abstract] [Full Text] [Related]

  • 14. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL.
    Brain Res; 1990 Sep 17; 527(2):234-43. PubMed ID: 1979237
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats.
    Eilam D, Clements KV, Szechtman H.
    Behav Brain Res; 1991 Nov 26; 45(2):117-24. PubMed ID: 1686397
    [Abstract] [Full Text] [Related]

  • 16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT, White FJ.
    Synapse; 1994 May 26; 17(1):43-61. PubMed ID: 7913772
    [Abstract] [Full Text] [Related]

  • 17. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH, Fechtali T, Rostain JC.
    Neuroscience; 1992 Sep 26; 50(2):395-402. PubMed ID: 1359460
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW, Qin ZH, Weiss B.
    Neuropsychopharmacology; 1991 Jan 26; 4(1):47-55. PubMed ID: 1672250
    [Abstract] [Full Text] [Related]

  • 19. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G, Ross SB, Kelder D, Edis LE, Jackson DM.
    Pharmacol Toxicol; 1990 Aug 07; 67(2):123-31. PubMed ID: 1979437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.